EUVIMEDEUVIMED entdecken
Crossref

Can Intraoperative Cricopharyngeus Muscle Characteristics Be Used to Predict Treatment Success in RCPD ?

Esther Lee iD, Matthew Shneyderman, Isabel Park, Bint-E Z Awan, Steven Bielamowicz iD

The Laryngoscope · 2026-07 · 136 (7) · 3111-3117

DOI: 10.1002/lary.70478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 10.03.2026. Verfasst von Esther Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, The George Washington University, Washington, DC, USA. Hauptthemen laut MEDLINE: Pharyngeal Muscles, Botulinum Toxins, Type A, Neuromuscular Agents, Muscular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate intraoperative findings as predictors for favorable outcomes following Botox injection in patients diagnosed with retrograde cricopharyngeus muscle dysfunction (RCPD).

Methods

A retrospective review was performed on patients who underwent 70–80 U botulinum toxin injection (BT) for treatment of RCPD by a single surgeon between 2018 and 2023. Patient characteristics, intraoperative findings of cricopharyngeus muscle (CPM), symptoms, treatment response, and side effects were identified during preoperative and 1‐month postoperative follow‐up.

Results

A total of 71 patients were included in the study. A majority of the patients were Caucasian ( n = 59 [83.1%]), female ( n = 37 [52.1%]), with a mean age of 29.2 years (SD = 8.3). Of those, 68% ( n = 48) of patients had a complete response to the initial Botox injection at 1‐month follow‐up. Compared to the mild thickness CPM, the moderate thickness CPM was 7.2 times less likely to have a full response to treatment (odds ratio [OR]: 7.24, confidence interval [CI]: 1.13–46.37, p = 0.037). Similarly, compared to the mild thickness CPM, thick CPM was 38.5 times less likely to have a full response to treatment (OR: 38.5, CI: 4.4–336.5, p = 0.001).

Conclusion

Moderate and thick CPMs were less likely to have resolution of symptoms after initial injection with 70–80 U of Botox injection. Further research is needed to establish recommendations regarding dosing for patients with RCPD, especially in those with moderate and thick CPMs. Level of Evidence 3

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pharyngeal MusclesBotulinum Toxins, Type ANeuromuscular AgentsMuscular DiseasesHumansFemaleRetrospective StudiesTreatment OutcomeMaleAdultIntraoperative Period

Stichwörter der Autor:innen

BotoxRCPDburpretrograde cricopharyngeus muscle dysfunction

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, The George Washington University, Washington, DC, USA.

ORCID-Profile: Esther Lee, Steven Bielamowicz

Zitieren

APA

Lee, E., Shneyderman, M., Park, I., Awan, B. Z., & Bielamowicz, S. (2026). Can Intraoperative Cricopharyngeus Muscle Characteristics Be Used to Predict Treatment Success in RCPD ?. The Laryngoscope, 136(7), 3111-3117. https://doi.org/10.1002/lary.70478

Vancouver

Lee E, Shneyderman M, Park I, Awan BZ, Bielamowicz S. Can Intraoperative Cricopharyngeus Muscle Characteristics Be Used to Predict Treatment Success in RCPD ?. The Laryngoscope. 2026;136(7):3111-3117. doi:10.1002/lary.70478

BibTeX
@article{Lee2026,
  author = {Lee, Esther and Shneyderman, Matthew and Park, Isabel and Awan, Bint-E Z and Bielamowicz, Steven},
  title = {Can Intraoperative Cricopharyngeus Muscle Characteristics Be Used to Predict Treatment Success in RCPD ?},
  journal = {The Laryngoscope},
  year = {2026},
  volume = {136},
  number = {7},
  pages = {3111--3117},
  doi = {10.1002/lary.70478}
}
Kostenlos starten →